Implantable tiles to improve cancer care
GT Medical’s GammaTile Therapy is an FDA-cleared surgically targeted radiation therapy (STaRT) for operable brain tumors. The implantable tiles ensure that radiation therapy begins immediately at the time of brain tumor removal.
The company collected $10 million in financing in January 2019. It most recently garnered expanded FDA indication for patients with newly diagnosed malignant brain tumors in January of this year. –SW
Investors include: Bluestone Venture Partners, Arizona Tech Angels, Desert Angels, Medical Technology Venture Partners